1. Home
  2. NSSC vs MPLT Comparison

NSSC vs MPLT Comparison

Compare NSSC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$37.95

Market Cap

1.4B

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

BUY

Current Price

$38.53

Market Cap

1.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
NSSC
MPLT
Founded
1969
2018
Country
United States
United States
Employees
1061
133
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NSSC
MPLT
Price
$37.95
$38.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$48.17
$32.67
AVG Volume (30 Days)
464.1K
445.8K
Earning Date
05-04-2026
05-28-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$181,621,000.00
N/A
Revenue This Year
$13.63
N/A
Revenue Next Year
$10.05
N/A
P/E Ratio
$54.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.27
$12.24
52 Week High
$47.61
$37.61

Technical Indicators

Market Signals
Indicator
NSSC
MPLT
Relative Strength Index (RSI) 51.37 67.76
Support Level $37.43 $26.20
Resistance Level $38.25 N/A
Average True Range (ATR) 1.16 2.59
MACD 0.23 0.69
Stochastic Oscillator 56.41 96.70

Price Performance

Historical Comparison
NSSC
MPLT

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: